MAP2K6
Dual specificity mitogen-activated protein kinase kinase 6
Also known as: MAPKK6, MEK6, MKK6, MP2K6_HUMAN, PRKMK6, SAPKK3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52564
- Gene
- MAP2K6
- Ensembl
- ENSG00000108984
- Chromosome
- 17
- Canonical length
- 334 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the dual specificity protein kinase family, which functions as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein phosphorylates and activates p38 MAP kinase in response to inflammatory cytokines or environmental stress. As an essential component of p38 MAP kinase mediated signal transduction pathway, this gene is involved in many cellular processes such as stress induced cell cycle arrest, transcription activation and apoptosis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
334 residues, UniProt reviewed canonical sequence.
>P52564|MAP2K6
1 MSQSKGKKRN PGLKIPKEAF EQPQTSSTPP RDLDSKACIS IGNQNFEVKA DDLEPIMELG
61 RGAYGVVEKM RHVPSGQIMA VKRIRATVNS QEQKRLLMDL DISMRTVDCP FTVTFYGALF
121 REGDVWICME LMDTSLDKFY KQVIDKGQTI PEDILGKIAV SIVKALEHLH SKLSVIHRDV
181 KPSNVLINAL GQVKMCDFGI SGYLVDSVAK TIDAGCKPYM APERINPELN QKGYSVKSDI
241 WSLGITMIEL AILRFPYDSW GTPFQQLKQV VEEPSPQLPA DKFSAEFVDF TSQCLKKNSK
301 ERPTYPELMQ HPFFTLHESK GTDVASFVKL ILGDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP2K6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 41 nTPM
- rectum: 30 nTPM
- colon: 29 nTPM
- cervix: 25 nTPM
- tongue: 20 nTPM
- breast: 19 nTPM
Single-cell type
- bergmann glia: 652 nCPM
- myonuclei: 558 nCPM
- adipocytes: 276 nCPM
- neutrophils: 215 nCPM
- distal convoluted tubule cells: 200 nCPM
- endometrial luminal cells: 141 nCPM
Immune cell
- plasmacytoid DC: 79 nTPM
- neutrophil: 46 nTPM
- classical monocyte: 22 nTPM
- myeloid DC: 7.1 nTPM
- total PBMC: 6.2 nTPM
- naive B-cell: 5.2 nTPM
Brain region
- cerebellum: 43 nTPM
- choroid plexus: 35 nTPM
- white matter: 33 nTPM
- hypothalamus: 31 nTPM
- thalamus: 31 nTPM
- medulla oblongata: 30 nTPM
ReferencesPubMed · IEDB
Publications for MAP2K6 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis.
2024 · Rheumatology (Oxford) · RCR 0.3 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 3.01
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- bone development
- cardiac muscle contraction
- cellular senescence
- MAPK cascade
- negative regulation of cold-induced thermogenesis
- nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway
- osteoblast differentiation
- p38MAPK cascade
- positive regulation of MAPK cascade
- regulation of cell cycle
- regulation of signal transduction by p53 class mediator
- signal transduction
- signal transduction in response to DNA damage
- stress-activated MAPK cascade
- stress-activated protein kinase signaling cascade
Molecular functions
- ATP binding
- identical protein binding
- MAP kinase kinase activity
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein tyrosine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP2K6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP2K6 as an antibody target. Whether an autoantibody or antibody against MAP2K6 could matter depends on whether native MAP2K6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP2K6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP2K6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...